Ginkgo Bioworks Holdings, Inc. (DNA) Stock Price, Quote & AI Analysis

Live DNA stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Ginkgo Bioworks Holdings, Inc..

TradeVae provides AI-driven analysis and real-time market intelligence for Ginkgo Bioworks Holdings, Inc. (DNA), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

DNA
Ginkgo Bioworks Holdings, Inc.
real-time
$0.00 +0.00 (+0.00%)
Open
6.890000
High
7.070000
Low
6.660000
Volume
1,490,813
VWAP
-
Market Cap
$415,512,401.92
52W Range
$5.00 - $17.58
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Ginkgo Bioworks Holdings, Inc.'s fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Ginkgo Bioworks Holdings, Inc. Overview

Company information

Company Overview

Ginkgo Bioworks Holdings, Inc. engages in developing biological engineering products and custom microbes. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment includes end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through its Canopy and Horizon offerings. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Company Details
Market Cap
$412.63M
Shares Outstanding
61,358,094
Weighted Shares Outstanding
61,924,352
CEO
Jason Kelly
Address
27 DRYDOCK AVENUE, BOSTON, MA, 02210
Employees
485
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
XNYS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Ginkgo Bioworks Holdings, Inc. Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...